Mesoblast - PDFSEARCH.IO - Document Search Engine

Mesoblast
Results: 104

#	Item
101	Constitution of Mesoblast Limited Melbourne office Ref: AXG.LGT[removed] Add to Reading List Source URL: www.mesoblast.com Language: English - Date: 2014-12-12 19:47:44 Investment Corporate finance Equity securities Corporations law Legal entities Preferred stock Australian Securities Exchange Corporation Stock Stock market Financial economics Business
102	Successful Outpatient Treatment of Refractory Crohn’s Disease Using Adult Mesenchymal Stem Cells Jane Onken, MD; Dianne Gallup, MS; John Hanson, MD; Michael Pandak, MD; Linda Custer, PhD, Duke Clinical Research Instit Add to Reading List Source URL: mesoblast.com Language: English* - Date: 2013-12-30 22:55:11 Infliximab Schering-Plough Pharmacology Medicine Monoclonal antibodies Centocor Immunosuppressants
103	Mesoblast Policy on Expanded Access Purpose To establish the Mesoblast policy for providing expanded access use of investigational medicinal products (IMP) to patients outside of a clinical trial. This policy applies glo Add to Reading List Source URL: www.mesoblast.com Language: English - Date: 2014-12-16 16:54:51 Health Clinical research Design of experiments Expanded access Clinical trial Regulatory requirement Food and Drug Administration ClinicalTrials.gov Institutional review board Pharmacology Research Pharmaceutical sciences
104	Allogeneic Human Mesenchymal Stem Cell Therapy (remestemcel-L, Prochymal®) as a Rescue Agent for Severe Refractory Acute GvHD in Pediatric Patients Add to Reading List Source URL: www.mesoblast.com Language: English - Date: 2013-12-30 23:23:27 Health Transplantation medicine Graft-versus-host disease Hematopoietic stem cell transplantation Cell therapy Immunosuppressive drug Mesenchymal stem cell Stem cell treatments Center for International Blood and Marrow Transplant Research Medicine Biology Stem cells

UPDATE